Skip to main content
https://pbs.twimg.com/media/GaNhjTKWIAAa-4F.jpg
#SLE and biologics (approved & under study) - Full read review: Anifrolumab Belimumab Ocrelizumab Obinutuzumab Ofatumumab Veltuzumab Epratuzumab Tocilizumab Secukinumab Ustekinumab Eculizumab https://t.co/EwplhAPYJH https://t.co/7Vgn2Rtd4f
Dr. John Cush
Oct-19-2024
×